Sher AA et al. |
[Interactions in the system of copper ion-azalide (azithromycin)]. |
1994 Sep-Oct |
Antibiot. Khimioter. |
pmid:7695446
|
Iur'ev SIu et al. |
[Azithromycin levels in the chorion tissue within the first three months of the pregnancy term]. |
2004 |
Antibiot. Khimioter. |
pmid:15850052
|
Iakovlev SV and Ukhin SA |
[Azithromycin: general properties and regimen optimization based on pharmacokinetic and pharmacological parameters]. |
2003 |
Antibiot. Khimioter. |
pmid:12803047
|
Sidorenko SV |
[Azithromycin--an antibiotic of the azalide group]. |
1993 |
Antibiot. Khimioter. |
pmid:8060181
|
Lopatkin NA et al. |
[Use of azithromycin ("Sumamded") in the treatment of infectious-inflammatory diseases of the lower urinary tract and male genitalia]. |
1993 |
Antibiot. Khimioter. |
pmid:8060189
|
Euba B et al. |
Relationship between azithromycin susceptibility and administration efficacy for nontypeable Haemophilus influenzae respiratory infection. |
2015 |
Antimicrob. Agents Chemother. |
pmid:25712355
|
Liu P et al. |
Comparative pharmacokinetics of azithromycin in serum and white blood cells of healthy subjects receiving a single-dose extended-release regimen versus a 3-day immediate-release regimen. |
2007 |
Antimicrob. Agents Chemother. |
pmid:17060516
|
Soltow SM and Brenner GM |
Synergistic activities of azithromycin and amphotericin B against Naegleria fowleri in vitro and in a mouse model of primary amebic meningoencephalitis. |
2007 |
Antimicrob. Agents Chemother. |
pmid:17060522
|
Beringer P et al. |
Absolute bioavailability and intracellular pharmacokinetics of azithromycin in patients with cystic fibrosis. |
2005 |
Antimicrob. Agents Chemother. |
pmid:16304166
|
Ulrich M et al. |
Moxifloxacin and azithromycin but not amoxicillin protect human respiratory epithelial cells against streptococcus pneumoniae in vitro when administered up to 6 hours after challenge. |
2005 |
Antimicrob. Agents Chemother. |
pmid:16304181
|
Kohlhoff SA et al. |
In vitro activity of AZD0914, a novel DNA gyrase inhibitor, against Chlamydia trachomatis and Chlamydia pneumoniae. |
2014 |
Antimicrob. Agents Chemother. |
pmid:25288086
|
Bosnar M et al. |
Cellular uptake and efflux of azithromycin, erythromycin, clarithromycin, telithromycin, and cethromycin. |
2005 |
Antimicrob. Agents Chemother. |
pmid:15917536
|
Singh S et al. |
Antimycobacterial drugs modulate immunopathogenic matrix metalloproteinases in a cellular model of pulmonary tuberculosis. |
2014 |
Antimicrob. Agents Chemother. |
pmid:24890593
|
Turcinov D et al. |
Failure of azithromycin in treatment of Brill-Zinsser disease. |
2000 |
Antimicrob. Agents Chemother. |
pmid:10817744
|
Tsitsika A et al. |
Single-oral-dose azithromycin prophylaxis against experimental streptococcal or staphylococcal aortic valve endocarditis. |
2000 |
Antimicrob. Agents Chemother. |
pmid:10817749
|
Bin XX et al. |
Effect of azithromycin plus rifampin versus amoxicillin alone on eradication and inflammation in the chronic course of Chlamydia pneumoniae pneumonitis in mice. |
2000 |
Antimicrob. Agents Chemother. |
pmid:10817751
|
Johnson MM et al. |
Effect of carbon dioxide on testing of susceptibilities of respiratory tract pathogens to macrolide and azalide antimicrobial agents. |
1999 |
Antimicrob. Agents Chemother. |
pmid:10428903
|
Kuo CC et al. |
In vitro activities of azithromycin, clarithromycin, and other antibiotics against Chlamydia pneumoniae. |
1996 |
Antimicrob. Agents Chemother. |
pmid:8913488
|
Credito KL et al. |
Activity of telithromycin (HMR 3647) against anaerobic bacteria compared to those of eight other agents by time-kill methodology. |
1999 |
Antimicrob. Agents Chemother. |
pmid:10428930
|
Pacifico L et al. |
Comparative efficacy and safety of 3-day azithromycin and 10-day penicillin V treatment of group A beta-hemolytic streptococcal pharyngitis in children. |
1996 |
Antimicrob. Agents Chemother. |
pmid:8849215
|
Unemo M et al. |
First three Neisseria gonorrhoeae isolates with high-level resistance to azithromycin in Sweden: a threat to currently available dual-antimicrobial regimens for treatment of gonorrhea? |
2014 |
Antimicrob. Agents Chemother. |
pmid:24189248
|
Li H et al. |
Meta-analysis of the adverse effects of long-term azithromycin use in patients with chronic lung diseases. |
2014 |
Antimicrob. Agents Chemother. |
pmid:24189261
|
Navarro G et al. |
Image-based 384-well high-throughput screening method for the discovery of skyllamycins A to C as biofilm inhibitors and inducers of biofilm detachment in Pseudomonas aeruginosa. |
2014 |
Antimicrob. Agents Chemother. |
pmid:24295976
|
Blais J et al. |
Inhibition of Toxoplasma gondii protein synthesis by azithromycin. |
1993 |
Antimicrob. Agents Chemother. |
pmid:8215287
|
Dever LL et al. |
Comparative in vitro activities of clarithromycin, azithromycin, and erythromycin against Borrelia burgdorferi. |
1993 |
Antimicrob. Agents Chemother. |
pmid:8215288
|
Edelstein PH and Edelstein MA |
In vitro activity of azithromycin against clinical isolates of Legionella species. |
1991 |
Antimicrob. Agents Chemother. |
pmid:1849708
|
Kosowska K et al. |
Activities of two novel macrolides, GW 773546 and GW 708408, compared with those of telithromycin, erythromycin, azithromycin, and clarithromycin against Haemophilus influenzae. |
2004 |
Antimicrob. Agents Chemother. |
pmid:15504829
|
Biedenbach DJ et al. |
Determination of CEM-101 activity tested against clinical isolates of Neisseria meningitidis from a worldwide collection. |
2010 |
Antimicrob. Agents Chemother. |
pmid:20625152
|
Piesman J et al. |
Efficacy of an experimental azithromycin cream for prophylaxis of tick-transmitted lyme disease spirochete infection in a murine model. |
2014 |
Antimicrob. Agents Chemother. |
pmid:24165183
|
Nahata MC et al. |
Pharmacokinetics of azithromycin in pediatric patients with acute otitis media. |
1995 |
Antimicrob. Agents Chemother. |
pmid:7486938
|
Chisholm SA et al. |
High-level azithromycin resistance occurs in Neisseria gonorrhoeae as a result of a single point mutation in the 23S rRNA genes. |
2010 |
Antimicrob. Agents Chemother. |
pmid:20585125
|
Tomazic J et al. |
Ex vivo effect of azithromycin in human leukocyte bactericidal functions. |
1995 |
Antimicrob. Agents Chemother. |
pmid:7486947
|
Deshpande D et al. |
Azithromycin Dose To Maximize Efficacy and Suppress Acquired Drug Resistance in Pulmonary Mycobacterium avium Disease. |
2016 |
Antimicrob. Agents Chemother. |
pmid:26810646
|
Azoulay-Dupuis E et al. |
Prophylactic and therapeutic activities of azithromycin in a mouse model of pneumococcal pneumonia. |
1991 |
Antimicrob. Agents Chemother. |
pmid:1656849
|
Chinh NT et al. |
A randomized controlled comparison of azithromycin and ofloxacin for treatment of multidrug-resistant or nalidixic acid-resistant enteric fever. |
2000 |
Antimicrob. Agents Chemother. |
pmid:10858343
|
Amacher DE et al. |
Comparison of the effects of the new azalide antibiotic, azithromycin, and erythromycin estolate on rat liver cytochrome P-450. |
1991 |
Antimicrob. Agents Chemother. |
pmid:1656856
|
Fass RJ |
Erythromycin, clarithromycin, and azithromycin: use of frequency distribution curves, scattergrams, and regression analyses to compare in vitro activities and describe cross-resistance. |
1993 |
Antimicrob. Agents Chemother. |
pmid:8257127
|
Gunell M et al. |
In vitro activity of azithromycin against nontyphoidal Salmonella enterica. |
2010 |
Antimicrob. Agents Chemother. |
pmid:20498312
|
Roblin PM and Hammerschlag MR |
Microbiologic efficacy of azithromycin and susceptibilities to azithromycin of isolates of Chlamydia pneumoniae from adults and children with community-acquired pneumonia. |
1998 |
Antimicrob. Agents Chemother. |
pmid:9449287
|
Pfefferkorn ER and Borotz SE |
Comparison of mutants of Toxoplasma gondii selected for resistance to azithromycin, spiramycin, or clindamycin. |
1994 |
Antimicrob. Agents Chemother. |
pmid:8141576
|
Pene Dumitrescu T et al. |
Development of a population pharmacokinetic model to describe azithromycin whole-blood and plasma concentrations over time in healthy subjects. |
2013 |
Antimicrob. Agents Chemother. |
pmid:23629714
|
Gelber RH et al. |
Activities of various macrolide antibiotics against Mycobacterium leprae infection in mice. |
1991 |
Antimicrob. Agents Chemother. |
pmid:1648889
|
Caronzolo D et al. |
Glucocorticoids increase in vitro and in vivo activities of antibiotics against Chlamydophila pneumoniae. |
2004 |
Antimicrob. Agents Chemother. |
pmid:15561871
|
Carter G et al. |
A subinhibitory concentration of clarithromycin inhibits Mycobacterium avium biofilm formation. |
2004 |
Antimicrob. Agents Chemother. |
pmid:15561879
|
Sjölund Karlsson M et al. |
Outbreak of infections caused by Shigella sonnei with reduced susceptibility to azithromycin in the United States. |
2013 |
Antimicrob. Agents Chemother. |
pmid:23274665
|
Dreses-Werringloer U et al. |
Effects of azithromycin and rifampin on Chlamydia trachomatis infection in vitro. |
2001 |
Antimicrob. Agents Chemother. |
pmid:11600348
|
Tateda K et al. |
Azithromycin inhibits quorum sensing in Pseudomonas aeruginosa. |
2001 |
Antimicrob. Agents Chemother. |
pmid:11353657
|
Donati M et al. |
In vitro activities of several antimicrobial agents against recently isolated and genotyped Chlamydia trachomatis urogenital serovars D through K. |
2010 |
Antimicrob. Agents Chemother. |
pmid:20855744
|
Bergman KL et al. |
Antimicrobial activities and postantibiotic effects of clarithromycin, 14-hydroxy-clarithromycin, and azithromycin in epithelial cell lining fluid against clinical isolates of haemophilus influenzae and Streptococcus pneumoniae. |
1999 |
Antimicrob. Agents Chemother. |
pmid:10223956
|
Akova M et al. |
In vitro activities of antibiotics alone and in combination against Brucella melitensis at neutral and acidic pHs. |
1999 |
Antimicrob. Agents Chemother. |
pmid:10223958
|